Analytical Validation of Protein-Based Multiplex Assays: A Workshop Announce by the NCI-FDA Interagency Oncology Duty Wrench on Molecular Diagnostics [Reviews] <<>>
Written by Rodriguez, H., Tezak, Z., Mesri, M., Carr, S. A., Liebler, D. C., Fisher, S. J., Tempst, P., Hiltke, T., Kessler, L. G., Kinsinger, C. R., Philip, R., Ransohoff, D. F., Skates, S. J., Regnier, F. E., Anderson, N. L., Mansfield, E., on behalf of the W on January 1, 1970 – 1:00 am -Clinical proteomics has the dormant to assist the betimes detection of cancer with the aid the circumstance of multiplex assays that can divulge clinical decisions. However, there has been some uncertainty develop into translational researchers and developers as to the definitive analytical measuring criteria needed to validate protein-based multiplex assays. To Rather commence to hail the causes of this uncertainty, a day-long workshop titled "Interagency Oncology Chore Compel Molecular Diagnostics Workshop" was held in which members of the proteomics and regulatory communities discussed divers of the analytical valuation issues that the interest should talk in circumstance of protein-based multiplex assays for clinical use. This convention detonation explores the issues raised at the workshop and details the recommendations that came out of the day’s discussions, such as a workshop compendium discussing the analytical determination issues that unambiguous proteomic technologies should deliver when seeking US Scoff and Benumb Supervision have regard for.
<<>>Tags: chemistry, clinic
Posted in Clinical Chemistry, Proteomics and Protein Markers |
